Rankings
▼
Calendar
AQST FY 2016 Earnings — Aquestive Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
AQST
Aquestive Therapeutics, Inc.
$424M
FY 2016 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$52M
Gross Profit
$35M
68.4% margin
Operating Income
-$847,000
-1.6% margin
Net Income
-$10M
-18.5% margin
EPS (Diluted)
$-0.39
Cash Flow
Operating Cash Flow
-$8M
Free Cash Flow
-$9M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$39M
Total Liabilities
$57M
Stockholders' Equity
-$18M
Cash & Equivalents
$9M
← Q1 2017
All Quarters
